Address |
200 Route 31 North Flemington New Jersey 08822 United States |
Employees | - |
Website | http://www.arnothera.com |
Updated | 07/08/2019 |
Arno Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. It develops pre-clinical and clinical-stage product under the following brands: Onapristone, AR-42, and AR-12. The company was founded by Peter Morgan Kash, David M. |